The impact of advanced medical therapies on time to resection and colorectal cancer outcomes in ulcerative colitis patients undergoing colectomy
Despite increased usage of advanced medical therapies, time to resection and CRC rates have remained unchanged in UC patients undergoing colectomy over the past 2 decades. Advanced therapy patients had higher incidental cancers rates, associated with decreased CRC survival. Awareness of timely colectomy is crucial for this group.
Authors
- André D’Hoore
- Antonio Luberto (ORCID: https://orcid.org/0000-0002-1202-9447)
- Severine A.R.A. Vermeire (ORCID: https://orcid.org/0000-0001-9942-3019)
- Roel Hompes (ORCID: https://orcid.org/0000-0001-6094-8950)
- Gabriele Bislenghi (ORCID: https://orcid.org/0000-0002-9212-9287)
- Lianne Heuthorst (ORCID: https://orcid.org/0000-0002-6961-0996)
- Willem A. Bemelman (ORCID: https://orcid.org/0000-0002-1037-9945)
- Geert D’Haens (ORCID: https://orcid.org/0000-0003-2784-4046)
- Christianne J. Buskens (ORCID: https://orcid.org/0000-0001-9425-8683)
- Eva Visser (ORCID: https://orcid.org/0009-0000-1432-9606)
Institutions
- Amsterdam University Medical Centers (NL)
- KU Leuven (BE)
Publication Details
- Journal
- Journal of Crohn s and Colitis
- Published
- 2025-01-23
- DOI
- https://doi.org/10.1093/ecco-jcc/jjaf015
- Citations
- 4
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 7.27
Funders
- Pfizer